Founded Year

2019

Stage

Seed VC - II | Alive

Total Raised

$8.17M

Last Raised

$4.06M | 15 days ago

Mosaic Score

+220 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About iLoF

iLoF enables a new era of personalized medicine by using AI and photonics to build a cloud-based library of disease biomarkers and biological profiles. It is enabling biotechs and pharmaceutical companies to make clinical trials faster, cheaper, and more patient-centric. The platform pulls together massive amounts of data to build a library of biological profiles, bringing together physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. The company was founded in 2019 and is based in London, England.

iLoF Headquarter Location

Unit 6 Queens Yard, White Post Lane

London, England, E9 5EN,

United Kingdom

+44 01865 679064

iLoF's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

iLoF's Products & Differentiation

See iLoF's products and how their products differentiate from alternatives and competitors

  • iLoF

    Agnostic platform using Artificial Intelligence and photonics to screen patient from biological samples based on their biological profiles or disease biomarkers

    Differentiation

    Our pricing model guarantees cost savings for clients 

    Reproducible and accurate (specificity and sensitivity both over 90%) 

    Minimally invasive and simple (work on fluid biosamples such as plasma or serum) 

    Agnostic and label-free (works both on current gold standard biomarkers, as in future targets) 

    Non-destructive (samples can be reused, and analysis can be done on thawed samples) 

    Rapid, portable test (< 30 seconds, can be done centralized or locally) 

    Multiple healthcare applications 

    The key selling point of our services focus on solving the largest pain point of our immediate targeted users: the bottleneck created in the patient recruitment process, where invasive procedures, a… 

Research containing iLoF

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned iLoF in 3 CB Insights research briefs, most recently on Dec 8, 2021.

Expert Collections containing iLoF

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

iLoF is included in 4 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

B

Biopharma Tech

838 items

Latest iLoF News

Innovative Digital Health startup iLoF Raises $5m investment

Jul 28, 2022

iLoF Secures Funding to Expand its Digital Library of Biomarkers Aimed at Tackling the World’s Deadliest Diseases.

iLoF Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

iLoF Rank

  • When was iLoF founded?

    iLoF was founded in 2019.

  • Where is iLoF's headquarters?

    iLoF's headquarters is located at Unit 6 Queens Yard, White Post Lane, London.

  • What is iLoF's latest funding round?

    iLoF's latest funding round is Seed VC - II.

  • How much did iLoF raise?

    iLoF raised a total of $8.17M.

  • Who are the investors of iLoF?

    Investors of iLoF include M12, Berggruen Holdings, Charlie Songhurst, Alter Venture Partners, re.Mind Capital and 11 more.

  • Who are iLoF's competitors?

    Competitors of iLoF include lino Biotech and 3 more.

  • What products does iLoF offer?

    iLoF's products include iLoF.

You May Also Like

P
Probius

Probius is an all-electronic platform for fingerprinting of biological specimens in preclinical and food safety applications.

l
lino Biotech

lino Biotech provides focal molography, which is a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells.

L
Lasers4Life

Lasers4Life seeks to develop a method based on the unique properties of ultrashort laser pulses that will enable doctors to diagnose cancers at the earliest possible stage.

P
Pre Diagnostics

Pre Diagnostics is a Norwegian diagnostic company that seeks to create value for patients, partners, and investors by developing patient-friendly, in-vitro diagnostic (IVD) products for early detection of diseases. The company's proprietary concept is built upon the scientific premise that a disease evokes systemic responses in macrophages unique to that disease which can be accurately measured in the blood samples of patients.

Cytiva Logo
Cytiva

Cytiva, formerly GE Healthcare Life Sciences, is a provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Accelerating growth, productivity, and innovation in the sector are major strategic focus areas for the company, as global demand for personalized and advanced biological therapies is ever-increasing. Cytiva drives customer-centered innovation, from idea to commercial development stages, with facilities across Asia, Europe, and the Americas. It also has centers for customer collaboration and training to enable the development of new therapies, such as the Testa Center in Uppsala, Sweden and the University of Technology at Sydney.

Sartorius Logo
Sartorius

The Sartorius Group is an international partner of life science research and the biopharmaceutical industry. With laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The company was founded in 1987 and is based in Goettingen, Germany.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.